Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AtriCure (ATRC) Return on Sales (2016 - 2025)

AtriCure (ATRC) has disclosed Return on Sales for 16 consecutive years, with 0.01% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Sales rose 14.0% to 0.01% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.02%, a 7.0% increase, with the full-year FY2025 number at 0.02%, up 7.0% from a year prior.
  • Return on Sales was 0.01% for Q4 2025 at AtriCure, up from 0.0% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 1.38% in Q3 2021 to a low of 0.29% in Q1 2021.
  • A 5-year average of 0.03% and a median of 0.08% in 2023 define the central range for Return on Sales.
  • Peak YoY movement for Return on Sales: surged 147bps in 2021, then plummeted -153bps in 2022.
  • AtriCure's Return on Sales stood at 0.19% in 2021, then skyrocketed by 75bps to 0.05% in 2022, then plummeted by -94bps to 0.09% in 2023, then plummeted by -36bps to 0.13% in 2024, then surged by 110bps to 0.01% in 2025.
  • Per Business Quant, the three most recent readings for ATRC's Return on Sales are 0.01% (Q4 2025), 0.0% (Q3 2025), and 0.05% (Q2 2025).